AIVO Journal

AIVO Journal

The Leading Voice on AI Visibility Governance

Pharma Case Study 1: Platform-Dependent Treatment Recommendation Divergence in Oncology

Pharma Case Study 1: Platform-Dependent Treatment Recommendation Divergence in Oncology

Abstract Conversational AI systems are increasingly used at the point of therapeutic choice in oncology. In structured decision-stage testing across multiple leading AI systems, identical treatment-selection questions produced materially different “preferred therapy” outcomes depending solely on platform. The divergence did not arise from guideline deviation or factual error. It emerged
3 min read
What Uncontaminated Observation Can and Cannot Prove

What Uncontaminated Observation Can and Cannot Prove

Context The previous analyses in this series established two related problems: external AI systems now generate decision-relevant representations without organisational visibility, and optimisation-first approaches contaminate the evidentiary record organisations later need to evaluate their own interventions. The governance implication follows directly: Observation must precede intervention. The next question is therefore
4 min read
The Evidence: A Record of Observed Behaviour in External AI Systems

The Evidence: A Record of Observed Behaviour in External AI Systems

Why this record exists External AI systems now generate decision-relevant descriptions of enterprises on a continuous basis. These descriptions influence purchasing decisions, risk assessments, regulatory understanding, and reputational trust, often before stakeholders engage with any owned or official enterprise channels. Despite this influence, such representations are typically ephemeral, non-logged, and
5 min read